MSL 109 (MACRT)

MSL-109 monoclonal antibody against CMV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSL 109 (MACRT), covering 2012-10-25 to 2012-10-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) [Phase 2]